DK202882A - Fremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater - Google Patents

Fremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater Download PDF

Info

Publication number
DK202882A
DK202882A DK202882A DK202882A DK202882A DK 202882 A DK202882 A DK 202882A DK 202882 A DK202882 A DK 202882A DK 202882 A DK202882 A DK 202882A DK 202882 A DK202882 A DK 202882A
Authority
DK
Denmark
Prior art keywords
carbon atoms
group
alkyl
alkyl group
compounds
Prior art date
Application number
DK202882A
Other languages
English (en)
Other versions
DK164937B (da
DK164937C (da
Inventor
F L-E Arvidsson
P A E Carlsson
U A Hacksell
J S M Hjorth
P L Lindberg
J L G Nilsson
D Sanchez
H V Wikstroem
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of DK202882A publication Critical patent/DK202882A/da
Publication of DK164937B publication Critical patent/DK164937B/da
Application granted granted Critical
Publication of DK164937C publication Critical patent/DK164937C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK202882A 1981-05-08 1982-05-06 Analogifremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater eller farmaceutisk acceptable syreadditionssalte deraf samt 1-alkyl-2-aminotetralinderivater til anvendelse som udgangsmateriale i fremgangsmaaden DK164937C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8102908 1981-05-08
SE8102908 1981-05-08

Publications (3)

Publication Number Publication Date
DK202882A true DK202882A (da) 1982-11-09
DK164937B DK164937B (da) 1992-09-14
DK164937C DK164937C (da) 1993-02-01

Family

ID=20343779

Family Applications (1)

Application Number Title Priority Date Filing Date
DK202882A DK164937C (da) 1981-05-08 1982-05-06 Analogifremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater eller farmaceutisk acceptable syreadditionssalte deraf samt 1-alkyl-2-aminotetralinderivater til anvendelse som udgangsmateriale i fremgangsmaaden

Country Status (16)

Country Link
US (1) US4876284A (da)
EP (1) EP0064964B1 (da)
JP (1) JPS57192344A (da)
AT (1) ATE8874T1 (da)
AU (2) AU554206B2 (da)
CA (1) CA1236113A (da)
DE (1) DE3260529D1 (da)
DK (1) DK164937C (da)
ES (4) ES511986A0 (da)
FI (1) FI78067C (da)
GR (1) GR77121B (da)
IE (1) IE53143B1 (da)
IL (1) IL65501A (da)
NO (1) NO152902C (da)
NZ (1) NZ200526A (da)
PH (2) PH18065A (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
US4743618A (en) * 1983-01-03 1988-05-10 Nelson Research & Development Co. Substituted 2-aminotetralins
US4657925A (en) * 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US4722933A (en) * 1985-12-20 1988-02-02 Nelson Research & Development Co. Substituted 2-aminotetralins
GB2157950B (en) * 1984-05-04 1988-11-02 Nelson Res & Dev Selective d-2 dopamine receptor agonist
AU573828B2 (en) * 1984-05-17 1988-06-23 E.R. Squibb & Sons, Inc. Tetrahydronaphthalenols
DE3479314D1 (en) * 1984-05-22 1989-09-14 Nelson Res & Dev Substituted 2-aminotetralins and processes for synthesis
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
WO1990001476A1 (en) * 1988-07-29 1990-02-22 Schering Corporation A PROCESS FOR THE ENANTIOSPECIFIC SYNTHESIS OF INTERMEDIATES FOR HEXAHYDRO-BENZO[d]NAPHTHO[2,1-b]AZEPINES
US5091526A (en) * 1988-07-29 1992-02-25 Schering Corporation Process for the enantiospecific synthesis of intermediates for hexahydro-benzo[d]-naphtho[2,1-b]azepines
CA1335106C (en) * 1989-02-27 1995-04-04 John Mehnert Schaus Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
CA2051399C (en) * 1989-05-31 2003-12-30 Chiu-Hong Lin Therapeutically useful 2-aminotetralin derivatives
IT1232160B (it) * 1989-07-31 1992-01-25 Sigma Tau Ind Farmaceuti 2-(n-acil)ammino-6,7-dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono
JPH05503517A (ja) * 1989-12-18 1993-06-10 バージニア・コモンウェルス・ユニバーシティ シグマレセプターリガンド及びその用途
DE69124868T2 (de) * 1990-08-15 1997-07-10 Lilly Co Eli Ring-substituierte 2-Amino-1,2,3,4-tetra-hydronaphthaline, 3-Aminochromane und 3-Aminothiochromane
CA2106197A1 (en) * 1991-04-26 1992-10-27 Montford F. Piercey Method of treating/preventing substance abuse
EP0591426A4 (en) * 1991-06-27 1996-08-21 Univ Virginia Commonwealth Sigma receptor ligands and the use thereof
IT1251877B (it) * 1991-09-26 1995-05-26 Zambon Spa Processo per la preparazione di 2-ammino-5,6 dimetossi-tetralina
EP0697894A4 (en) * 1993-03-31 1996-05-01 Univ Pennsylvania DOPAMINE D-3 AND SEROTONIN (5-HT 1A) RECEPTOR LIGANDS AND IMAGING AGENTS
CA2166100A1 (en) * 1993-06-23 1995-01-05 Richard A. Glennon Sigma receptor ligands and the use thereof
GB9315566D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Medicaments
JPH11503116A (ja) * 1995-03-27 1999-03-23 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 二環式アミン誘導体および抗精神病薬としてのそれらの使用
US5646188A (en) * 1995-07-05 1997-07-08 Teva Pharmaceutical Industries, Ltd. Polyamine derivatives of 1-aminoindan
NZ510988A (en) * 1998-10-07 2005-01-28 Ortho Mcneil Pharm Inc N-aralkylaminotetralins useful as ligands for the neuropeptide Y5 receptor
WO2003097586A1 (en) 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
DE102010020553A1 (de) 2010-05-14 2011-11-17 Bayer Schering Pharma Aktiengesellschaft Substituierte 8-Alkoxy-2-aminotetralin-Derivate und ihre Verwendung
JP6324956B2 (ja) 2012-07-20 2018-05-16 バイエル・ファルマ・アクティエンゲゼルシャフト 置換アミノインダン−およびアミノテトラリンカルボン酸ならびにその使用
AU2013292046C1 (en) 2012-07-20 2018-03-15 Bayer Pharma Aktiengesellschaft Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
JP2025501309A (ja) 2021-12-29 2025-01-17 バイエル アクツィエンゲゼルシャフト 心肺障害の治療
AR128147A1 (es) 2021-12-29 2024-03-27 Bayer Ag Procedimiento para la preparación del ácido (5s)-[2-(4-carboxifenil)etil][2-(2-[3-cloro-4’-(trifluorometil)bifenil-4-il]metoxifenil)etil]amino-5,6,7,8-tetrahidroquinolina-2-carboxílico y sus formas cristalinas para su uso como compuesto farmacéuticamente activo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1017359A (en) * 1972-07-03 1977-09-13 Frederic P. Hauck Substituted cyclic polymethylene phenols
JPS5124508B2 (da) * 1972-08-14 1976-07-24
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
DE3062971D1 (en) * 1979-09-14 1983-06-09 Sandoz Ag Derivatives of tetraline, their preparation and medicaments containing these compounds
AU7179781A (en) * 1980-05-29 1981-12-21 Astra Lakemedel Aktiebolag Therapeutically useful tetralin derivatives
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
FR2512814A1 (fr) * 1981-09-16 1983-03-18 Synthelabo Derives d'amino-2 tetrahydro-1,2,3,4 naphtalene, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
FI78067C (fi) 1989-06-12
IE821076L (en) 1982-11-08
ES8506591A1 (es) 1985-08-01
FI821598A0 (fi) 1982-05-06
ES8306708A1 (es) 1983-06-01
FI78067B (fi) 1989-02-28
JPH0419221B2 (da) 1992-03-30
ES519615A0 (es) 1985-05-01
IL65501A0 (en) 1982-07-30
NO152902C (no) 1985-12-11
DE3260529D1 (en) 1984-09-13
GR77121B (da) 1984-09-07
ES8504666A1 (es) 1985-05-01
NZ200526A (en) 1985-09-13
PH19585A (en) 1986-05-26
IL65501A (en) 1986-04-29
DK164937B (da) 1992-09-14
NO152902B (no) 1985-09-02
EP0064964A1 (en) 1982-11-17
ES535882A0 (es) 1985-12-01
US4876284A (en) 1989-10-24
CA1236113A (en) 1988-05-03
AU572497B2 (en) 1988-05-12
EP0064964B1 (en) 1984-08-08
AU2587984A (en) 1984-06-28
ATE8874T1 (de) 1984-08-15
JPS57192344A (en) 1982-11-26
IE53143B1 (en) 1988-07-20
NO821494L (no) 1982-11-09
AU554206B2 (en) 1986-08-14
ES8602603A1 (es) 1985-12-01
FI821598L (fi) 1982-11-09
ES511986A0 (es) 1983-06-01
DK164937C (da) 1993-02-01
ES529311A0 (es) 1985-08-01
AU8340982A (en) 1982-11-11
PH18065A (en) 1985-03-18

Similar Documents

Publication Publication Date Title
DK202882A (da) Fremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
EP0132764A3 (en) New compounds derived from diphenyl-methylene-ethylamine
DE3362328D1 (en) (1-arylcyclobutyl) (heterocyclyl) methylamine compounds, their preparation and their use as therapeutic agents
NO923413D0 (no) Terapeutiske benzazepin-forbindelser
ES543804A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dialquilaminoalcoxi sustituido y de sus sa-les de adicion acidas y amonicas cuaternarias
LV10607A (lv) Jauni bicikliski aminoaizvietoti savienojumi
NO823125L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-amino-naftalen-derivater
NO872574D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
ES550742A0 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
SE8303719D0 (sv) Novel eburnane oxime derivatives and process for preparing same
AU527523B2 (en) Hexahydro-1,4-oxazepines
SE8302452D0 (sv) Method for treatment of senile dementia
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas

Legal Events

Date Code Title Description
PBP Patent lapsed